Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.105 AUD | +5.24% |
|
+11.62% | +256.45% |
07-02 | Mesoblast to File Biological License Application with US FDA for Cellular Therapy | MT |
07-01 | Mesoblast to File Biologics License Application for Ryoncil | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+256.45% | 806M | |
+16.59% | 44.44B | |
+42.83% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- MSB Stock
- News Mesoblast Limited
- Mesoblast to File Biologics License Application for Ryoncil